{
  "docId": "019de070-9f9d-7718-acb6-17a3db6270ac",
  "docSlug": "7a58434f86a94bb0eba92fad9f688c31",
  "documentTitle": "23andMe | SPAC Presentation Deck | 47 slides",
  "authorId": "23andme",
  "authorName": "23andMe",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2021-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 30,
  "pageCount": 47,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "Uses a funnel metaphor to represent the narrowing of research focus from broad data to specific drug targets.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-9f9d-7718-acb6-17a3db6270ac/30",
  "deckHref": "/decks/019de070-9f9d-7718-acb6-17a3db6270ac",
  "deckJsonHref": "/decks/019de070-9f9d-7718-acb6-17a3db6270ac.json",
  "deckAnchorHref": "/decks/019de070-9f9d-7718-acb6-17a3db6270ac#slide-30",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.55,
        "x": 0.07,
        "y": 0.2
      },
      "kind": "diagram",
      "text": "10,000's of Genome-Wide Association Study (GWAS) Hits; Determine Disease Associated Genes and Directionality; Researching to Understand Compelling Biology; Identifying Druggable Proteins; Phenome-Wide Association Studies (PheWAS) Reveal Additional Indications and Potential Safety Concerns; Assessment of Unmet Need and Competitive Landscape; Best Drug Targets",
      "attrs": null,
      "subkind": "funnel",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3211180a-33af-4507-b181-ee75a3056aae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "framework",
      "text": "Funnel process",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dc62a100-db35-43c5-be3d-69a27171cdd8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.25,
        "x": 0.7,
        "y": 0.2
      },
      "kind": "list",
      "text": "23andMe’s database yields thousands of potential new drug targets; Advanced biology and medicinal chemistry guide design of optimal compounds from initial targets; Phenotypic breadth provides unique ability to uncover potential safety issues or possible indication expansions",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a688573f-bf31-43af-b2e4-f140771bc0ce",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.55,
        "x": 0.07,
        "y": 0.82
      },
      "kind": "paragraph",
      "text": "Wet lab validated targets progress through standard stages of research toward the selection of preclinical lead molecules and clinical development",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f576ecf-dacc-4bd4-a12a-ed3ab0530220",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.7,
        "x": 0.15,
        "y": 0.05
      },
      "kind": "title",
      "text": "Systematic, Scalable Research Platform Yields Novel Drug Targets",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "19125d8d-e48b-4df0-95ec-7aab15a22e64",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "83553625-7c12-40b8-8737-4871c25b25c4",
      "evidence": "Funnel diagram showing sequential stages of drug discovery",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 30,
      "from": 21,
      "beatId": "128379fa-90aa-4c0d-b5c6-fef3f5f859b3",
      "arcName": "Rags to Riches",
      "arcSlug": "rags-to-riches",
      "beatName": "The Breakthrough",
      "beatSlug": "rags-to-riches-the-breakthrough",
      "evidence": "The deck presents 23andMe's breakthroughs in therapeutics discovery and development",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 30,
      "from": 26,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "f21fb50b-1139-4a89-a2de-f93a9b6f603d",
      "evidence": "The deck highlights the limitations of current therapeutics development approaches",
      "position": 1,
      "objective": "The cost of inaction in therapeutics development",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}